a month ago
DYN
AnalystsDebjit ChattopadhyayDebjit Chattopadhyay's Stock Forecasts
AnalystsDebjit Chattopadhyay
Sectors:
Industries:
Analyst Ranking
Top 30%
#1372 out of 4554 analysts
Average Return
+1.7%
Win Rate
45%22 out of 49
Risk vs Reward
Poor
Good
Debjit Chattopadhyay's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Jounce Therapeutics IncJNCE | +158.50% | $4.94 | $12.77 | 2020-03-01 - 2021-03-02 | Buy |
Sarepta Therapeutics IncSRPT | +134.33% | $55.25 | $129.47 | 2017-11-30 - 2018-11-30 | Buy |
Centessa Pharmaceuticals PLCCNTA | +126.94% | $4.64 | $10.53 | 2023-06-11 - 2024-04-18 | Strong Buy |
Krystal Biotech IncKRYS | +99.10% | $81.91 | $163.08 | 2023-02-27 - 2024-02-28 | Strong Buy |
Precision Biosciences IncDTIL | +81.66% | $194.70 | $353.70 | 2020-03-10 - 2021-03-11 | Buy |
Debjit Chattopadhyay Analyst Color
Get additional color on Debjit Chattopadhyay's coverage of popular stocks
2 months ago
KRYS
Debjit Chattopadhyay's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $450.00 | +14.36% | Maintains | a day ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $22.00 | +191.39% | Initiates Coverage On | 24 days ago |
Dyne Therapeutics IncDYN | 2 | Strong Buy | $37.00 | +56.45% | Maintains | a month ago |
Prime Medicine IncPRME | 2 | Strong Buy | $20.00 | +335.73% | Maintains | a month ago |
Krystal Biotech IncKRYS | 3 | Strong Buy | $175.00 | +6.73% | Maintains | 2 months ago |
Newamsterdam Pharma Co NvNAMS | 1 | Strong Buy | $30.00 | +54.32% | Initiates Coverage On | 3 months ago |
Soleno Therapeutics IncSLNO | 1 | Strong Buy | $40.00 | +7.67% | Assumes | 5 months ago |
Biomarin Pharmaceutical IncBMRN | 3 | Strong Buy | $110.00 | +22.13% | Reiterates | 7 months ago |
Centessa Pharmaceuticals PLCCNTA | 2 | Strong Buy | $10.00 | -5.03% | Maintains | 8 months ago |
Uniqure NvQURE | 3 | Strong Buy | $53.00 | N/A | Reiterates | a year ago |
Allogene Therapeutics IncALLO | 1 | Buy | $29.00 | N/A | Maintains | a year ago |
Passage Bio IncPASG | 2 | Strong Buy | $11.00 | N/A | Maintains | a year ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | $50.00 | N/A | Upgrades | 2 years ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Ionis Pharmaceuticals IncIONS | 1 | Strong Buy | $64.00 | N/A | Initiates Coverage On | 2 years ago |
Beam Therapeutics IncBEAM | 1 | Strong Buy | $130.00 | N/A | Initiates Coverage On | 2 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 2 years ago |
Intellia Therapeutics IncNTLA | 1 | Strong Buy | $170.00 | N/A | Initiates Coverage On | 3 years ago |
Tourmaline Bio IncTRML | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 3 years ago |
Freeline Therapeutics Holdings PLCFRLN | 1 | Strong Buy | $255.00 | N/A | Initiates Coverage On | 3 years ago |
Sarepta Therapeutics IncSRPT | 4 | Buy | $221.00 | N/A | Maintains | 4 years ago |
Galapagos NvGLPG | 3 | Hold | $123.00 | N/A | Downgrades | 4 years ago |
Sierra Oncology IncSRRA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Avrobio IncAVRO | 2 | Hold | $13.00 | N/A | Downgrades | 4 years ago |
Precision Biosciences IncDTIL | 1 | Buy | $570.00 | N/A | Maintains | 4 years ago |
Zymeworks IncZYME | 1 | Buy | $60.00 | N/A | Reiterates | 4 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $10.00 | N/A | Reiterates | 4 years ago |
Wave Life Sciences LtdWVE | 1 | Buy | $20.00 | N/A | Maintains | 4 years ago |
Immunogen IncIMGN | 2 | Hold | $3.50 | N/A | Downgrades | 5 years ago |
Audentes Therapeutics IncBOLD1 | 1 | Buy | $33.00 | N/A | Maintains | 6 years ago |
Global Blood Therapeutics IncGBT | 4 | Buy | $125.00 | N/A | Maintains | 6 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.